1-155066988-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_005227.3(EFNA4):c.372C>T(p.Phe124Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00507 in 1,612,832 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0045 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 41 hom. )
Consequence
EFNA4
NM_005227.3 synonymous
NM_005227.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.06
Publications
10 publications found
Genes affected
EFNA4 (HGNC:3224): (ephrin A4) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 1-155066988-C-T is Benign according to our data. Variant chr1-155066988-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 710307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.06 with no splicing effect.
BS2
High AC in GnomAd4 at 685 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFNA4 | NM_005227.3 | c.372C>T | p.Phe124Phe | synonymous_variant | Exon 2 of 4 | ENST00000368409.8 | NP_005218.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EFNA4 | ENST00000368409.8 | c.372C>T | p.Phe124Phe | synonymous_variant | Exon 2 of 4 | 1 | NM_005227.3 | ENSP00000357394.3 | ||
| EFNA4 | ENST00000359751.8 | c.372C>T | p.Phe124Phe | synonymous_variant | Exon 2 of 4 | 1 | ENSP00000352789.4 | |||
| EFNA4-EFNA3 | ENST00000505139.1 | c.113+3052C>T | intron_variant | Intron 1 of 4 | 2 | ENSP00000426741.1 | ||||
| EFNA4 | ENST00000427683.2 | c.372C>T | p.Phe124Phe | synonymous_variant | Exon 2 of 4 | 2 | ENSP00000414378.2 |
Frequencies
GnomAD3 genomes AF: 0.00450 AC: 685AN: 152202Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
685
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00464 AC: 1160AN: 249734 AF XY: 0.00472 show subpopulations
GnomAD2 exomes
AF:
AC:
1160
AN:
249734
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00512 AC: 7484AN: 1460512Hom.: 41 Cov.: 32 AF XY: 0.00512 AC XY: 3721AN XY: 726482 show subpopulations
GnomAD4 exome
AF:
AC:
7484
AN:
1460512
Hom.:
Cov.:
32
AF XY:
AC XY:
3721
AN XY:
726482
show subpopulations
African (AFR)
AF:
AC:
19
AN:
33438
American (AMR)
AF:
AC:
79
AN:
44536
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
26042
East Asian (EAS)
AF:
AC:
3
AN:
39694
South Asian (SAS)
AF:
AC:
312
AN:
86046
European-Finnish (FIN)
AF:
AC:
851
AN:
53256
Middle Eastern (MID)
AF:
AC:
20
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
5955
AN:
1111432
Other (OTH)
AF:
AC:
243
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
428
855
1283
1710
2138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00450 AC: 685AN: 152320Hom.: 4 Cov.: 32 AF XY: 0.00483 AC XY: 360AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
685
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
360
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
35
AN:
41564
American (AMR)
AF:
AC:
73
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5184
South Asian (SAS)
AF:
AC:
13
AN:
4828
European-Finnish (FIN)
AF:
AC:
179
AN:
10620
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
359
AN:
68032
Other (OTH)
AF:
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Mar 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
EFNA4: BP4, BP7, BS2
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.